Light baryon static properties in a dispersive approach
Physical Review D · 29.06.2026 · 113 (11)
DOI: 10.1103/yf12-mv85 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review D, online erschienen am 29.06.2026. Verfasst von Shuge Zeng und 2 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Council.
Abstract (Originalsprache)
We extend our dispersive analyses on meson static properties to those of light baryons. The formalism treats the dispersion relation, which a baryonic correlation function obeys, as an inverse problem, solves for the involved spectral density with available operator-product-expansion (OPE) inputs directly, and extracts baryon static properties from the spectral density. We observe that the simultaneous implementation of the chiral-even and chiral-odd dispersive constraints unambiguously determines baryon masses and pole residues. A common set of quark and gluon condensates, which appear in OPE factorization and are universal, is found to accommodate the masses of a ρ meson, a proton, and a Δ ( 1232 ) baryon. The advantage of our approach over the conventional handling of QCD sum rules is advocated. This work encourages broad applications of our nonperturbative analytical method to baryon systems.
Förderung
- National Natural Science Foundation of China
- National Science and Technology Council
Zitieren
APA
Zeng, S., Li, H., & Xu, F. (2026). Light baryon static properties in a dispersive approach. Physical Review D, 113(11). https://doi.org/10.1103/yf12-mv85
Vancouver
Zeng S, Li H, Xu F. Light baryon static properties in a dispersive approach. Physical Review D. 2026;113(11). doi:10.1103/yf12-mv85
BibTeX
@article{Zeng2026,
author = {Zeng, Shuge and Li, Hsiang-nan and Xu, Fanrong},
title = {Light baryon static properties in a dispersive approach},
journal = {Physical Review D},
year = {2026},
volume = {113},
number = {11},
doi = {10.1103/yf12-mv85}
}
EUVIMED